SO

Suzanne Ostrand-Rosenberg

UB University Of Maryland, Baltimore: 6 patents #49 of 1,115Top 5%
DI Dana-Farber Cancer Institute: 4 patents #223 of 1,343Top 20%
Harvard University: 4 patents #525 of 3,600Top 15%
GI Genetics Institute: 1 patents #199 of 327Top 65%
RE Repligen: 1 patents #56 of 102Top 55%
UM University Of Maryland: 1 patents #209 of 857Top 25%
📍 Columbia, MD: #140 of 1,501 inventorsTop 10%
🗺 Maryland: #3,562 of 35,612 inventorsTop 15%
Overall (All Time): #570,666 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10377810 Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients 2019-08-13
9650429 Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients 2017-05-16
8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients 2015-02-17
8444965 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines Jacobus J. Bosch, Bruce Ksander 2013-05-21
8026224 Tumor cells with increased immunogenicity and uses therfor Sivasubramanina Baskar, Laurie H. Glimcher, Gordon J. Freeman, Lee M. Nadler 2011-09-27
7807186 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines Jacobus J. Bosch, Bruce Ksander 2010-10-05
6319709 Tumor cells with increased immunogenicity and uses therefor Sivasubramanian Baskar, Laurie H. Glimcher, Gordon J. Freeman, Lee M. Nadler 2001-11-20
6149905 Tumor cells with increased immunogenicity and uses therefor Sivasubramanian Baskar, Laurie H. Glimcher, Gordon J. Freeman, Lee M. Nadler 2000-11-21
5858776 Tumor cells with increased immunogenicity and uses therefor Sivasubramanian Baskar, Laurie H. Glimcher, Gordon J. Freeman, Lee M. Nadler 1999-01-12